"World's Most Complete Market Research Reports Repository"

Global Active Pharmaceutical Ingredients Market Research Report 2011-2023

Summary
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The global Active Pharmaceutical Ingredients market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Synthetic APIs
Biotech APIs
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy?s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Synthetic APIs
1.2.1.2 Biotech APIs
1.2.2 by Application
1.2.2.1 CNS
1.2.2.2 Cardiovascular
1.2.2.3 Genitourinary/Hormonal Drugs
1.2.2.4 Respiratory
1.2.2.5 Rheumatology
1.2.2.6 Diabetes
1.2.2.7 Oncology
1.2.2.8 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Synthetic APIs Market, 2011-2016
4.1.2 Biotech APIs Market, 2011-2016
4.2 Market Forecast
4.2.1 Synthetic APIs Market Forecast, 2017-2022
4.2.2 Biotech APIs Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 CNS Market, 2011-2016
5.1.2 Cardiovascular Market, 2011-2016
5.1.3 Genitourinary/Hormonal Drugs Market, 2011-2016
5.1.4 Respiratory Market, 2011-2016
5.1.5 Rheumatology Market, 2011-2016
5.1.6 Diabetes Market, 2011-2016
5.1.7 Oncology Market, 2011-2016
5.1.8 Others Market, 2011-2016
5.2 Market Forecast
5.2.1 CNS Market Forecast, 2017-2022
5.2.2 Cardiovascular Market Forecast, 2017-2022
5.2.3 Genitourinary/Hormonal Drugs Market Forecast, 2017-2022
5.2.4 Respiratory Market Forecast, 2017-2022
5.2.5 Rheumatology Market Forecast, 2017-2022
5.2.6 Diabetes Market Forecast, 2017-2022
5.2.7 Oncology Market Forecast, 2017-2022
5.2.8 Others Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Teva
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Mylan
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 DSM
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Aurobindo Pharma
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Aspen
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Novartis
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 BASF
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Pfizer
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Huahai Pharmaceutical
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Hisun Pharmaceutical
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 Sun Pharmaceutical Industries
8.12 Zhejiang Medicine
8.13 Dr. Reddy?s Laboratories
8.14 Zhejiang NHU
8.15 Bayer
8.16 NCPC
8.17 AbbVie
8.18 Shandong Xinhua Pharmaceutical
8.19 Northeast Pharm
8.20 Harbin Pharmaceutical
8.21 LKPC
9 Conclusion

Table Product Specifications of Active Pharmaceutical Ingredients
Table Products Segment of Active Pharmaceutical Ingredients
Table Synthetic APIs Overview
Table Biotech APIs Overview
Table Global Active Pharmaceutical Ingredients Market by Type, 2011-2022 (USD Million)
Table Application Segment of Active Pharmaceutical Ingredients
Table CNS Overview
Table Cardiovascular Overview
Table Genitourinary/Hormonal Drugs Overview
Table Respiratory Overview
Table Rheumatology Overview
Table Diabetes Overview
Table Oncology Overview
Table Others Overview
Table Global Active Pharmaceutical Ingredients Market by Application, 2011-2022 (USD Million)
Table Global Active Pharmaceutical Ingredients Market by Region, 2011-2022 (USD Million)
Table Cost of Active Pharmaceutical Ingredients
Table Market Dynamics
Table Policy of Active Pharmaceutical Ingredients
Table GDP of Major Countries
Table Synthetic APIs CAGR by Revenue and Volume, 2011-2016
Table Biotech APIs CAGR by Revenue and Volume, 2011-2016
Table Synthetic APIs CAGR by Revenue and Volume, 2012-2022
Table Biotech APIs CAGR by Revenue and Volume, 2012-2022
Table CNS CAGR by Revenue and Volume, 2011-2016
Table Cardiovascular CAGR by Revenue and Volume, 2011-2016
Table Genitourinary/Hormonal Drugs CAGR by Revenue and Volume, 2011-2016
Table Respiratory CAGR by Revenue and Volume, 2011-2016
Table Rheumatology CAGR by Revenue and Volume, 2011-2016
Table Diabetes CAGR by Revenue and Volume, 2011-2016
Table Oncology CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016

Choose License Type